Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Animalcare ( (GB:ANCR) ).
Animalcare Group plc reported a strong trading performance for the full year ending 31 December 2024, with revenue and EBITDA aligning with market expectations. The company achieved a 4.9% increase in revenue, driven by demand for key products such as the Plaqtiv+ oral health range and the Daxocox brand. The completion of the Randlab acquisition at the start of 2025 supports the company’s strategic expansion into new markets, despite a rise in net debt to £11.5 million due to transaction expenses. The company’s robust financial platform positions it well for pursuing further growth opportunities.
More about Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation that operates in seven European countries, as well as Australia and New Zealand, exporting to approximately 40 countries worldwide. The Group is focused on bringing new and innovative products to market through its development pipeline, partnerships, and acquisitions.
YTD Price Performance: -1.64%
Average Trading Volume: 55,618
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £165.5M
See more data about ANCR stock on TipRanks’ Stock Analysis page.
